Liu Yingjie, director of Science and Technology Innovation Bureau of Pingshan District, Shenzhen, led a team to investigate Shenzhen Cell Valley
On January 16, 2024, Liu Yingjie, Director of Science and Technology Innovation Bureau of Pingshan District, Shenzhen, led a team to investigate Shenzhen Cell Valley to understand the production and operation of Shenzhen Cell Valley, and provide help for the development of enterprises and biomedical industry. Shi Yuanyuan, chairman and general manager of Shenzhen Cell Valley, and Wang Jianxun, chief scientist of Shenzhen Cell Valley, warmly received and carried out discussions and exchanges.
First of all, Director Liu Yingjie of Pingshan District Science and Technology Innovation Bureau, accompanied by Chairman Shi Yuanyuan, visited the smart exhibition hall, production workshop and research and development laboratory, and learned about the company's founder team, enterprise development history, cell therapy history and status quo, service platform construction and corporate vision. In the emerging industry of biomedicine, Shenzhen Cell Valley provides pharmaceutical companies with the whole industry chain service of "R&D - production - declaration - talent training" of original cell drugs, enabling the development of the field of cell and gene therapy.
At the symposium, Chairman Shi Yuanyuan warmly welcomed the visit of the leaders of the District Science and Technology Innovation Bureau, and explained in detail the industry background of cell and gene therapy, market development trend, and the advantages of GMP industrial production of retroviral vector, the company's core technology. Mr. Liu Yingjie attached great importance to enterprises in the biomedical field. He said that enterprises in the biomedical field should seize policy opportunities, continuously improve their innovation and service capabilities, and cultivate technical talents with professional knowledge and a sense of industry mission to achieve sustainable development of the industry. The District Science and Innovation Bureau will be committed to continuously optimizing the policy environment, providing enterprises with convenient and efficient services, providing precise support in key links, making every effort to build the whole biomedical industry chain ecosystem, focusing on industrial foresight issues in the biomedical field, promoting the integration and innovation of the upstream and downstream of the industrial chain and between enterprises, integrating the innovation chain with the industrial chain, and optimizing the regional layout of industrial development. Form a regional characteristic cluster of biomedicine industry with core competitiveness.
Chairman Shi Yuanyuan expressed his sincere thanks to Director Liu Yingjie for the attention and support of Shenzhen Cell Valley and the field of cell and gene therapy. Shenzhen Cell Valley will always adhere to the original intention of "cells benefit all beings, genes create the future", carry forward the spirit of scientific research, keep up with the trend of policy development, provide a full range of services for product research and development and transformation of results, make full use of advanced technology and talent reserves, help the construction of cell and gene therapy industry chain, and make positive contributions to promote the high development of domestic cell and gene therapy industry.
